$ RGBP Regen BioPharma, Inc. Nears Completion Of Optimizing Its Lead NR2F6 Small Molecule Agonist "Company is preparing for efficacy experiments in mice" #FDA #StockInPlay @frontpagestocks https://www.thestreet.com/story/14529815/1/regen-biopharma-inc-nears-completion-of-optimizing-its-lead-nr2f6-small-molecule-agonist.html